Retinopathy in Persons Without Diabetes: the Handan Eye Study
Overview
Authors
Affiliations
Purpose: To describe the prevalence and associations of retinopathy in a population-based nondiabetic sample of rural Chinese.
Design: Population-based cross-sectional study.
Participants: We included 6830 Han Chinese aged > or =30 years from 13 villages of Yongnian County, Handan City, Hebei Province, China.
Methods: All participants underwent a standardized interview and extensive examinations including retinal photography, measurement of blood pressure (BP) and fasting plasma glucose (FPG). Diabetes mellitus was defined as either FPG > or = 7.0 mmol/l, use of diabetic medication or a physician diagnosis of diabetes. Photographic grading of retinopathy followed the modified Early Treatment Diabetic Retinopathy Study classification system. Logistic regression models were used to assess associations of retinopathy.
Main Outcome Measures: Any retinopathy.
Results: The prevalence of retinopathy among participants without diabetes was 13.6% (95% confidence interval [CI], 12.6-14.6%). The age and gender standardized prevalence of retinopathy in the Chinese adult population (aged 30+ years) without diabetes was estimated to be 12.1% (95% CI 11.1-12.9%). Independent risk factors associated with retinopathy were age (odds ratio [OR], 1.02 ; 95% CI 1.01-1.03 per year increase), male gender (male vs. female, OR 1.27; 95% CI 1.08-1.49), higher FPG (OR 1.30; 95% CI 1.11-1.53 per mmol/l increase), higher systolic BP (OR 1.15; 95% CI 1.05-1.27 per 10 mmHg increase) and higher diastolic BP (OR 1.16; 95% CI 1.09-1.22 per 10 mmHg increase).
Conclusions: Retinopathy was common among rural Chinese adults without diabetes. Its association with FPG and BP suggests that early microvascular damage is occurring at "high normal" levels of blood glucose and BP.
Determination of osteopontin in monitoring retinal damage in metabolic syndrome.
DAmico R, Siracusa R, Cordaro M, Fusco R, Interdonato L, Franco G Int J Exp Pathol. 2024; 105(6):206-218.
PMID: 39397270 PMC: 11576325. DOI: 10.1111/iep.12518.
Kellner R, Harris A, Ciulla L, Guidoboni G, Verticchio Vercellin A, Oddone F J Clin Med. 2024; 13(3).
PMID: 38337522 PMC: 10856197. DOI: 10.3390/jcm13030829.
Ma Y, Wang H, Jiang J, Han C, Lu C, Zeng S Front Endocrinol (Lausanne). 2022; 13:966619.
PMID: 36004355 PMC: 9393865. DOI: 10.3389/fendo.2022.966619.
Yongpeng Z, Yaxing W, Jinqiong Z, Qian W, Yanni Y, Xuan Y Front Public Health. 2022; 10:922289.
PMID: 35923972 PMC: 9339787. DOI: 10.3389/fpubh.2022.922289.
Cheung C, Biousse V, Keane P, Schiffrin E, Wong T Nat Rev Dis Primers. 2022; 8(1):14.
PMID: 35273180 DOI: 10.1038/s41572-022-00342-0.